Rasmussen脑炎的临床、病理及治疗进展The2005EuropeanconsensusremainstheacceptedguidelineforevaluativecriteriaRasmussen’sencephalitis:clinicalfeatures,pathobiology,andtreatmentadvances
LancetNeurol2014;13:195–205Rasmussen脑炎(RE)临床特点•aprogressivedisease•drug-resistantfocalepilepsy•progressivehemiplegia(偏瘫)•cognitivedecline•withunihemispheric(单侧半球)brainatrophy流行病学•主要见于儿童,平均发病年龄6岁,婴幼儿到青年均可见•German:2-4casesper10millionpeopleaged18yearsandyoungerperyear•UK:anincidenceof1-7per10millionpeopleaged16yearsandyoungerperyear•性别、地理位置、种族等未见明显差异ThreediseasestagesRE•Prodromalstage:Non-specific,lowseizurefrequency,andmildhemiplegia•Acutestage:Frequentseizures,oftenepilepsiapartialiscontinua(EPC);progressivehemiparesis,hemianopia(偏盲),cognitivedeterioration,andaphasia(失语)(ifdominanthemisphereaffected)•Residualstage:Permanent